AAC -- The 20 Most-Frequently Read Articles in Antimicrob. Agents Chemother.

The 20 Most-Frequently Read Articles
in Antimicrob. Agents Chemother. during October 2009 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

1. Spotswood L. Spruance, Julia E. Reid, Michael Grace, Matthew Samore
Hazard Ratio in Clinical Trials
Antimicrob. Agents Chemother. Aug 01, 2004; 48: 2787-2792.
(In "Minireviews")   [Full Text]     [PDF]

2. Tuberculosis Drug Screening Program
Search for New Drugs for Treatment of Tuberculosis
Antimicrob. Agents Chemother. Jul 01, 2001; 45: 1943-1946.
(In "Guest Commentary")   [Full Text]     [PDF]

3. Cody C. Cain, Dongho Lee, Robert H. Waldo III, Alexis T. Henry, Earl J. Casida, Mansukh C. Wani, Monroe E. Wall, Nicholas H. Oberlies, Joseph O. Falkinham III
Synergistic Antimicrobial Activity of Metabolites Produced by a Nonobligate Bacterial Predator
Antimicrob. Agents Chemother. Jul 01, 2003; 47: 2113-2117.
(In "Susceptibility")   [Abstract]     [Full Text]     [PDF]

4. Sarah Palmer, Robert W. Shafer, Thomas C. Merigan
Hydroxyurea Enhances the Activities of Didanosine, 9-[2-(Phosphonylmethoxy)ethyl]adenine, and 9-[2-(Phosphonylmethoxy)propyl]adenine against Drug-Susceptible and Drug-Resistant Human Immunodeficiency Virus Isolates
Antimicrob. Agents Chemother. Aug 01, 1999; 43: 2046-2050.
(In "Antiviral Agents")   [Abstract]     [Full Text]     [PDF]

5. Alexander Sulakvelidze, Zemphira Alavidze, J. Glenn Morris
Bacteriophage Therapy
Antimicrob. Agents Chemother. Mar 01, 2001; 45: 649-659.
(In "Minireviews")   [Full Text]     [PDF]

6. Bruno Périchon, Patrice Courvalin
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Antimicrob. Agents Chemother. Nov 01, 2009; 53: 4580-4587.
(In "Minireviews")   [Abstract]     [Full Text]     [PDF]

7. J. M. Rolain, P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, D. Raoult
Recommendations for Treatment of Human Infections Caused by Bartonella Species
Antimicrob. Agents Chemother. Jun 01, 2004; 48: 1921-1933.
(In "Minireviews")   [Full Text]     [PDF]

8. Robert E. W. Hancock, Daniel S. Chapple
Peptide Antibiotics
Antimicrob. Agents Chemother. Jun 01, 1999; 43: 1317-1323.
(In "Minireviews")   [Full Text]     [PDF]

9. DP Nicolau, CD Freeman, PP Belliveau, CH Nightingale, JW Ross, R Quintiliani
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Antimicrob. Agents Chemother. Mar 01, 1995; 39: 650-655.
(In "Articles")   [Abstract]     [PDF]

10. Bo Zheng, Haruyoshi Tomita, Takako Inoue, Yasuyoshi Ike
Isolation of VanB-Type Enterococcus faecalis Strains from Nosocomial Infections: First Report of the Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200, Encoding VanB-Type Vancomycin Resistance and a Bac41-Type Bacteriocin, and pMG2201, Encoding Erythromycin Resistance and Cytolysin (Hly/Bac)
Antimicrob. Agents Chemother. Feb 01, 2009; 53: 735-747.
(In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]

11. Leticia I. Llarrull, Jed F. Fisher, Shahriar Mobashery
Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New β-Lactams That Meet the Challenge
Antimicrob. Agents Chemother. Oct 01, 2009; 53: 4051-4063.
(In "Minireviews")   [Full Text]     [PDF]

12. Stephen H. Gillespie
Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective
Antimicrob. Agents Chemother. Feb 01, 2002; 46: 267-274.
(In "Minireviews")   [Full Text]     [PDF]

13. Marie-Paule Mingeot-Leclercq, Paul M. Tulkens
Aminoglycosides: Nephrotoxicity
Antimicrob. Agents Chemother. May 01, 1999; 43: 1003-1012.
(In "Minireviews")   [Full Text]     [PDF]

14. Aurélie Thiolas, Claude Bollet, Bernard La Scola, Didier Raoult, Jean-Marie Pagès
Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient
Antimicrob. Agents Chemother. Apr 01, 2005; 49: 1354-1358.
(In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]

15. Jong Hwa Lee, Ji-Hyun Shin, Im Hwan Roe, Seung Ghyu Sohn, Jung Hun Lee, Geun Ho Kang, Han-Ki Lee, Byeong Chul Jeong, Sang Hee Lee
Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults
Antimicrob. Agents Chemother. Apr 01, 2005; 49: 1600-1603.
(In "Clinical Therapeutics")   [Abstract]     [Full Text]     [PDF]

16. James Edwin Hall, John E. Kerrigan, Kishore Ramachandran, Brendan C. Bender, Jason P. Stanko, Susan K. Jones, Donald A. Patrick, Richard R. Tidwell
Anti-Pneumocystis Activities of Aromatic Diamidoxime Prodrugs
Antimicrob. Agents Chemother. Mar 01, 1998; 42: 666-674.
(In "Experimental Therapeutics")   [Abstract]     [Full Text]     [PDF]

17. Jossy van den Boogaard, Gibson S. Kibiki, Elton R. Kisanga, Martin J. Boeree, Rob E. Aarnoutse
New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
Antimicrob. Agents Chemother. Mar 01, 2009; 53: 849-862.
(In "Minireviews")   [Full Text]     [PDF]

18. Todd P. Levin, Byungse Suh, Peter Axelrod, Allan L. Truant, Thomas Fekete
Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure
Antimicrob. Agents Chemother. Mar 01, 2005; 49: 1222-1224.
(In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]

19. Pierre Forgacs, Nancy L. Wengenack, Leslie Hall, Sarah K. Zimmerman, Mark L. Silverman, Glenn D. Roberts
Tuberculosis and Trimethoprim-Sulfamethoxazole
Antimicrob. Agents Chemother. Nov 01, 2009; 53: 4789-4793.
(In "Susceptibility")   [Abstract]     [Full Text]     [PDF]

20. Françoise Dromer, Reynald Chevalier, Boualem Sendid, Luce Improvisi, Thierry Jouault, Raymond Robert, Jean Maurice Mallet, Daniel Poulain
Synthetic Analogues of ß-1,2 Oligomannosides Prevent Intestinal Colonization by the Pathogenic Yeast Candida albicans
Antimicrob. Agents Chemother. Dec 01, 2002; 46: 3869-3876.
(In "Experimental Therapeutics")   [Abstract]     [Full Text]     [PDF]

= from the current issue

Last Updated: 11/03/2009 02:51:14

1.	Spotswood L. Spruance, Julia E. Reid, Michael Grace, Matthew Samore
		Hazard Ratio in Clinical Trials
		Antimicrob. Agents Chemother. Aug 01, 2004; 48: 2787-2792. (In "Minireviews") [Full Text] [PDF]


2.	Tuberculosis Drug Screening Program
		Search for New Drugs for Treatment of Tuberculosis
		Antimicrob. Agents Chemother. Jul 01, 2001; 45: 1943-1946. (In "Guest Commentary") [Full Text] [PDF]


3.	Cody C. Cain, Dongho Lee, Robert H. Waldo III, Alexis T. Henry, Earl J. Casida, Mansukh C. Wani, Monroe E. Wall, Nicholas H. Oberlies, Joseph O. Falkinham III
		Synergistic Antimicrobial Activity of Metabolites Produced by a Nonobligate Bacterial Predator
		Antimicrob. Agents Chemother. Jul 01, 2003; 47: 2113-2117. (In "Susceptibility") [Abstract] [Full Text] [PDF]


4.	Sarah Palmer, Robert W. Shafer, Thomas C. Merigan
		Hydroxyurea Enhances the Activities of Didanosine, 9-[2-(Phosphonylmethoxy)ethyl]adenine, and 9-[2-(Phosphonylmethoxy)propyl]adenine against Drug-Susceptible and Drug-Resistant Human Immunodeficiency Virus Isolates
		Antimicrob. Agents Chemother. Aug 01, 1999; 43: 2046-2050. (In "Antiviral Agents") [Abstract] [Full Text] [PDF]


5.	Alexander Sulakvelidze, Zemphira Alavidze, J. Glenn Morris
		Bacteriophage Therapy
		Antimicrob. Agents Chemother. Mar 01, 2001; 45: 649-659. (In "Minireviews") [Full Text] [PDF]


6.	Bruno Périchon, Patrice Courvalin
		VanA-Type Vancomycin-Resistant Staphylococcus aureus
		Antimicrob. Agents Chemother. Nov 01, 2009; 53: 4580-4587. (In "Minireviews") [Abstract] [Full Text] [PDF]


7.	J. M. Rolain, P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, D. Raoult
		Recommendations for Treatment of Human Infections Caused by Bartonella Species
		Antimicrob. Agents Chemother. Jun 01, 2004; 48: 1921-1933. (In "Minireviews") [Full Text] [PDF]


8.	Robert E. W. Hancock, Daniel S. Chapple
		Peptide Antibiotics
		Antimicrob. Agents Chemother. Jun 01, 1999; 43: 1317-1323. (In "Minireviews") [Full Text] [PDF]


9.	DP Nicolau, CD Freeman, PP Belliveau, CH Nightingale, JW Ross, R Quintiliani
		Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
		Antimicrob. Agents Chemother. Mar 01, 1995; 39: 650-655. (In "Articles") [Abstract] [PDF]


10.	Bo Zheng, Haruyoshi Tomita, Takako Inoue, Yasuyoshi Ike
		Isolation of VanB-Type Enterococcus faecalis Strains from Nosocomial Infections: First Report of the Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200, Encoding VanB-Type Vancomycin Resistance and a Bac41-Type Bacteriocin, and pMG2201, Encoding Erythromycin Resistance and Cytolysin (Hly/Bac)
		Antimicrob. Agents Chemother. Feb 01, 2009; 53: 735-747. (In "Mechanisms Of Resistance") [Abstract] [Full Text] [PDF]


11.	Leticia I. Llarrull, Jed F. Fisher, Shahriar Mobashery
		Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New β-Lactams That Meet the Challenge
		Antimicrob. Agents Chemother. Oct 01, 2009; 53: 4051-4063. (In "Minireviews") [Full Text] [PDF]


12.	Stephen H. Gillespie
		Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective
		Antimicrob. Agents Chemother. Feb 01, 2002; 46: 267-274. (In "Minireviews") [Full Text] [PDF]


13.	Marie-Paule Mingeot-Leclercq, Paul M. Tulkens
		Aminoglycosides: Nephrotoxicity
		Antimicrob. Agents Chemother. May 01, 1999; 43: 1003-1012. (In "Minireviews") [Full Text] [PDF]


14.	Aurélie Thiolas, Claude Bollet, Bernard La Scola, Didier Raoult, Jean-Marie Pagès
		Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient
		Antimicrob. Agents Chemother. Apr 01, 2005; 49: 1354-1358. (In "Mechanisms Of Resistance") [Abstract] [Full Text] [PDF]


15.	Jong Hwa Lee, Ji-Hyun Shin, Im Hwan Roe, Seung Ghyu Sohn, Jung Hun Lee, Geun Ho Kang, Han-Ki Lee, Byeong Chul Jeong, Sang Hee Lee
		Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults
		Antimicrob. Agents Chemother. Apr 01, 2005; 49: 1600-1603. (In "Clinical Therapeutics") [Abstract] [Full Text] [PDF]


16.	James Edwin Hall, John E. Kerrigan, Kishore Ramachandran, Brendan C. Bender, Jason P. Stanko, Susan K. Jones, Donald A. Patrick, Richard R. Tidwell
		Anti-Pneumocystis Activities of Aromatic Diamidoxime Prodrugs
		Antimicrob. Agents Chemother. Mar 01, 1998; 42: 666-674. (In "Experimental Therapeutics") [Abstract] [Full Text] [PDF]


17.	Jossy van den Boogaard, Gibson S. Kibiki, Elton R. Kisanga, Martin J. Boeree, Rob E. Aarnoutse
		New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
		Antimicrob. Agents Chemother. Mar 01, 2009; 53: 849-862. (In "Minireviews") [Full Text] [PDF]


18.	Todd P. Levin, Byungse Suh, Peter Axelrod, Allan L. Truant, Thomas Fekete
		Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure
		Antimicrob. Agents Chemother. Mar 01, 2005; 49: 1222-1224. (In "Mechanisms Of Resistance") [Abstract] [Full Text] [PDF]


19.	Pierre Forgacs, Nancy L. Wengenack, Leslie Hall, Sarah K. Zimmerman, Mark L. Silverman, Glenn D. Roberts
		Tuberculosis and Trimethoprim-Sulfamethoxazole
		Antimicrob. Agents Chemother. Nov 01, 2009; 53: 4789-4793. (In "Susceptibility") [Abstract] [Full Text] [PDF]


20.	Françoise Dromer, Reynald Chevalier, Boualem Sendid, Luce Improvisi, Thierry Jouault, Raymond Robert, Jean Maurice Mallet, Daniel Poulain
		Synthetic Analogues of ß-1,2 Oligomannosides Prevent Intestinal Colonization by the Pathogenic Yeast Candida albicans
		Antimicrob. Agents Chemother. Dec 01, 2002; 46: 3869-3876. (In "Experimental Therapeutics") [Abstract] [Full Text] [PDF]